Crime
Again, Lai Mohammed makes another denial, states new position on repentant Boko Haram
Minister of Information and Culture Lai Mohammed has denied the reports he described as misleading attributed to him on the legal status of repentant Boko Haram terrorists.
The minister, who spoke in Washington DC. on Saturday, said he was misrepresented in the report in which he was quoted as saying federal government wouldn’t prosecute repentant terrorists, and that is best practice globally.
The minister reiterated his position that the call for the shooting of the repentant insurgents without profiling and prosecution was against best global practice.
The minister said his words were unambiguous and repeated what he said in the report.
“I personally spoke to the military authority before I left Nigeria and they said what they were doing is what the global practice dictates about soldiers that surrendered that should be treated as prisoners of war.
“You cannot just shoot them because there are international conventions that give rights also to prisoners of war.
“What the military is doing is that, when they surrender, they profile them to ensure that they are genuine and reintegrate them into the society,’’ he said.
He reiterated his position that the fact that the country was witnessing insurgents submitting in droves calls for commendation of the President Muhammadu Buhar and military for their doggedness.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

